CRIS peer analysis
Curis (CRIS) against its competitors: price, today's move, 1-year return and market value side by side.
CRIS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ASBP Aspire-Lakewood | $7.30 | -9.99% | -98.41% | – |
| BCTX Briacell Therapeutics | $3.09 | 1.64% | -72.80% | – |
| CTXR Citius Pharmaceuticals | $0.56 | 7.44% | -64.43% | $15.43M |
| ICU SeaStar Medical | $2.19 | -2.23% | -61.58% | – |
| PALI Palisade Bio | $1.12 | -3.45% | -45.89% | – |
| PCSA Processa Pharmaceuticals | $1.85 | -2.12% | -80.98% | – |
| CRIS Curis | $1.30 | 97.43% | -95.62% | $1.60M |
- CRIS's peers: ASBP (Aspire-Lakewood), BCTX (Briacell Therapeutics), CTXR (Citius Pharmaceuticals), ICU (SeaStar Medical), PALI (Palisade Bio), PCSA (Processa Pharmaceuticals).
Updated 2026-11-04 17:19 UTC